CPhI Worldwide

Short-Term Reshoring

The second part of the 2021 CPhI Annual Report looks ahead to predict the pharma manufacturing, therapeutic and technology environment in 2030.

Topics • Strategy

CPhI Worldwide Returns to Madrid

Top-Feature

Bio-Rad Laboratories

Dual‑Targeting Breakthroughs: Advancements in Bispecific Antibody Development

Concept Heidelberg

ECA Foundation Aims to Become Largest Pharma Association for GMP/GDP Compliance

Nova-Institut GmbH

Advanced Recycling Conference 2025: New Paths to the Circular Economy

CHEManager International c/o Wiley-VCH GmbH

20 Years of CHEManager International

MOC – Event Center Messe München

A successful concept on course for expansion — maintenance Munich 2025

Brenntag SE

Brenntag Downsizes Management Board, Retains Both Divisions

Interview

Strategic Response to a Shifting Pharma Landscape

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Informa Markets

Impress PR

CPhI Worldwide

Short-Term Reshoring

Patient Centricity: The New Nexus for CDMOs

CPhI Worldwide Announces International Advisory Board

CPhI Announces Founding Members of Expert Industry Panel

CPhI, PharmaEvolution to Analyze Pharma Industry in Monthly and Annual Reports